Minerva Neurosciences Inc (NERV) — Cash Flow Reinvestment Rate

Latest as of September 2017: 3.21x

Minerva Neurosciences Inc (NERV) has a Cash Flow Reinvestment Rate of 3.21x as of September 2017, reinvesting $79.80 Million (capex $0.00 plus investments $-79.80 Million) from operating cash flow of $24.89 Million. See Minerva Neurosciences Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

3.21x
(Capex + Investments) / Operating CF

Total Reinvested

$79.80 Million
Capex + Investments

Operating Cash Flow

$24.89 Million
USD

Capital Expenditures

$0.00
USD

Minerva Neurosciences Inc Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for Minerva Neurosciences Inc across 1 annual periods. For the full cash flow conversion analysis, see NERV operating cash flow.

Annual Cash Flow Reinvestment Rate for Minerva Neurosciences Inc (2017–2017)

Year-by-year capital reinvestment analysis for Minerva Neurosciences Inc. See Minerva Neurosciences Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2017 34.66x $107.19 Million $3.09 Million $52.40K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow